跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PAVBLU 40 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PAVBLU 40 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA
Approved
STANDARD
PAVBLU 40 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA
Amgen Technology (Ireland) Unlimited Company
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 9, 2025
Approval ID
d26156ee59069449
Company
Amgen Technology (Ireland) Unlimited Company
Type
Standard
Approval Details
Approval Id
d26156ee59069449
Drug Cima Aemps Name
PAVBLU 40 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA
Register Number
1251909001
Holder Company Name
Amgen Technology (Ireland) Unlimited Company
Marketing Company Name
Amgen S.A.
Holder Company Detail Path
/organization/amgen-technology-ireland-unlimited-company
Marketing Company Detail Path
/organization/amgen-sa
Authorization Date
2025-04-09
Dosage Form
SOLUCIÓN INYECTABLE
Dose
40 mg/ml
Route Of Administration
VÍA INTRAVÍTREA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Amgen Technology (Ireland) Unlimited Company
Company Detail Path
/organization/amgen-technology-ireland-unlimited-company
Company Information
Pharmaceutical Company Name
AMGEN TECHNOLOGY (IRELAND) UNLIMITED COMPANY
Country Name
Ireland
City Name
dun laoghaire,country_ie
Address
Pottery Road
Active Ingredients
AFLIBERCEPT
7 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 9, 2025
Approval ID
d26156ee59069449
Type
Standard
Back to CIMA-AEMPS Approvals